Influence
May 28, 2020

Medical panel cites Regenstrief, IU School of Medicine study in recommendations

Findings from a study conducted by Regenstrief Institute and Indiana University School of Medicine research scientists were cited by the U.S. Preventive Services Task Force in its announcement that it can neither recommend nor oppose cognitive screening for older adults in primary care.

The study, led by Nicole Fowler, PhD, MHSA, evaluated the pros and cons of screening older adults during primary care appointments. Results showed there were no differences in health-related quality of life, depression or anxiety, advance care planning, hospitalizations or emergency department visits between people who were screened and people who were not.

The CHOICE study is the first randomized controlled trial to assess both the potential harms and benefits of conducting cognitive screenings of older adults in primary care. The leaders of the study say the findings are important because they scientifically negate the concern that dementia screenings may be harmful to patients.

Members of the U.S. Preventive Services Task Force determined that this study and others currently do not offer conclusive evidence of benefits to screening for cognitive impairment, so it cannot make a recommendation for or against the screening. The task force’s work informs policies set by Medicare and private insurers.

Read the recommendation

Read some of the media coverage

Related News

LOINC® biannual stakeholder webinar to highlight latest updates and strategic initiatives

LOINC® biannual stakeholder webinar to highlight latest updates and strategic initiatives

LOINC® from Regenstrief Institute will host a biannual stakeholder meeting on March 25, 2025. During the meeting, held via

AI model predicting two-year risk of common heart disorder can easily be integrated into healthcare workflow

Non-invasive, inexpensive approach provides a practical option for proactive screening INDIANAPOLIS – AFib (short for atrial fibrillation), a common

Kun Huang, PhD

Predicting Alzheimer’s disease subtypes and understanding their molecular characteristics in living patients with transcriptomic trajectory profiling

Published in the Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association. Here is a link to the article.